Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

Monday’s trading has closed, but INCY is being traded in the after-hours session. After-Hours quote »
116.19
Delayed Data
As of 3:59pm ET
 -3.74 / -3.12%
Today’s Change
43.86
Today|||52-Week Range
121.93
+58.92%
Year-to-Date
No recent news for Incyte Corp.

Today’s Trading

Previous close119.93
Today’s open119.48
Day’s range115.82 - 121.93
Volume1,871,817
Average volume (3 months)1,117,700
Market cap$21.6B
Dividend yield--
Data as of 3:59pm ET, 08/31/2015

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+31.22%
Earnings growth (next 5 years)+199.00%
Revenue growth (last year)+44.10%
P/E ratio1,506.9
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-3.94-2.96%
ZTSZoetis Inc-0.91-1.99%
MYLMylan NV-0.78-1.55%
ENDPEndo International P...-1.70-2.16%
Data as of 4:14pm ET, 08/31/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

Partner Offers